IBDEI0A7 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4536,1,4,0)
 ;;=4^Z12.83
 ;;^UTILITY(U,$J,358.3,4536,2)
 ;;=^5062696
 ;;^UTILITY(U,$J,358.3,4537,0)
 ;;=Z48.817^^21^281^33
 ;;^UTILITY(U,$J,358.3,4537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4537,1,3,0)
 ;;=3^Surgical Aftercare Following Skin Surgery
 ;;^UTILITY(U,$J,358.3,4537,1,4,0)
 ;;=4^Z48.817
 ;;^UTILITY(U,$J,358.3,4537,2)
 ;;=^5063054
 ;;^UTILITY(U,$J,358.3,4538,0)
 ;;=L94.0^^21^281^18
 ;;^UTILITY(U,$J,358.3,4538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4538,1,3,0)
 ;;=3^Scleroderma,Localized
 ;;^UTILITY(U,$J,358.3,4538,1,4,0)
 ;;=4^L94.0
 ;;^UTILITY(U,$J,358.3,4538,2)
 ;;=^5009470
 ;;^UTILITY(U,$J,358.3,4539,0)
 ;;=D23.9^^21^281^20
 ;;^UTILITY(U,$J,358.3,4539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4539,1,3,0)
 ;;=3^Sebaceous Hyperplasia
 ;;^UTILITY(U,$J,358.3,4539,1,4,0)
 ;;=4^D23.9
 ;;^UTILITY(U,$J,358.3,4539,2)
 ;;=^5002076
 ;;^UTILITY(U,$J,358.3,4540,0)
 ;;=L21.9^^21^281^21
 ;;^UTILITY(U,$J,358.3,4540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4540,1,3,0)
 ;;=3^Seborrhea,Unspec
 ;;^UTILITY(U,$J,358.3,4540,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,4540,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,4541,0)
 ;;=L91.8^^21^281^25
 ;;^UTILITY(U,$J,358.3,4541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4541,1,3,0)
 ;;=3^Skin Tag
 ;;^UTILITY(U,$J,358.3,4541,1,4,0)
 ;;=4^L91.8
 ;;^UTILITY(U,$J,358.3,4541,2)
 ;;=^5009460
 ;;^UTILITY(U,$J,358.3,4542,0)
 ;;=I83.12^^21^281^28
 ;;^UTILITY(U,$J,358.3,4542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4542,1,3,0)
 ;;=3^Stasis Dermatitis.Left Leg
 ;;^UTILITY(U,$J,358.3,4542,1,4,0)
 ;;=4^I83.12
 ;;^UTILITY(U,$J,358.3,4542,2)
 ;;=^5007989
 ;;^UTILITY(U,$J,358.3,4543,0)
 ;;=I83.11^^21^281^27
 ;;^UTILITY(U,$J,358.3,4543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4543,1,3,0)
 ;;=3^Stasis Dermatitis,Right Leg
 ;;^UTILITY(U,$J,358.3,4543,1,4,0)
 ;;=4^I83.11
 ;;^UTILITY(U,$J,358.3,4543,2)
 ;;=^5007988
 ;;^UTILITY(U,$J,358.3,4544,0)
 ;;=B35.1^^21^282^9
 ;;^UTILITY(U,$J,358.3,4544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4544,1,3,0)
 ;;=3^Tinea Unguium
 ;;^UTILITY(U,$J,358.3,4544,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,4544,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,4545,0)
 ;;=F63.3^^21^282^12
 ;;^UTILITY(U,$J,358.3,4545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4545,1,3,0)
 ;;=3^Trichotillomania
 ;;^UTILITY(U,$J,358.3,4545,1,4,0)
 ;;=4^F63.3
 ;;^UTILITY(U,$J,358.3,4545,2)
 ;;=^5003643
 ;;^UTILITY(U,$J,358.3,4546,0)
 ;;=B35.2^^21^282^6
 ;;^UTILITY(U,$J,358.3,4546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4546,1,3,0)
 ;;=3^Tinea Manuum
 ;;^UTILITY(U,$J,358.3,4546,1,4,0)
 ;;=4^B35.2
 ;;^UTILITY(U,$J,358.3,4546,2)
 ;;=^5000605
 ;;^UTILITY(U,$J,358.3,4547,0)
 ;;=B35.6^^21^282^5
 ;;^UTILITY(U,$J,358.3,4547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4547,1,3,0)
 ;;=3^Tinea Cruris
 ;;^UTILITY(U,$J,358.3,4547,1,4,0)
 ;;=4^B35.6
 ;;^UTILITY(U,$J,358.3,4547,2)
 ;;=^119711
 ;;^UTILITY(U,$J,358.3,4548,0)
 ;;=B35.3^^21^282^8
 ;;^UTILITY(U,$J,358.3,4548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4548,1,3,0)
 ;;=3^Tinea Pedis
 ;;^UTILITY(U,$J,358.3,4548,1,4,0)
 ;;=4^B35.3
 ;;^UTILITY(U,$J,358.3,4548,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,4549,0)
 ;;=B35.4^^21^282^4
 ;;^UTILITY(U,$J,358.3,4549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4549,1,3,0)
 ;;=3^Tinea Corporis
 ;;^UTILITY(U,$J,358.3,4549,1,4,0)
 ;;=4^B35.4
 ;;^UTILITY(U,$J,358.3,4549,2)
 ;;=^119704
 ;;^UTILITY(U,$J,358.3,4550,0)
 ;;=L51.2^^21^282^11
 ;;^UTILITY(U,$J,358.3,4550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4550,1,3,0)
 ;;=3^Toxic Epidermal Necrolysis
 ;;^UTILITY(U,$J,358.3,4550,1,4,0)
 ;;=4^L51.2
